Correlation Between Boeing and Rigel Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Boeing and Rigel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Boeing and Rigel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between The Boeing and Rigel Pharmaceuticals, you can compare the effects of market volatilities on Boeing and Rigel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Boeing with a short position of Rigel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Boeing and Rigel Pharmaceuticals.

Diversification Opportunities for Boeing and Rigel Pharmaceuticals

-0.62
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Boeing and Rigel is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding The Boeing and Rigel Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rigel Pharmaceuticals and Boeing is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on The Boeing are associated (or correlated) with Rigel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rigel Pharmaceuticals has no effect on the direction of Boeing i.e., Boeing and Rigel Pharmaceuticals go up and down completely randomly.

Pair Corralation between Boeing and Rigel Pharmaceuticals

Allowing for the 90-day total investment horizon Boeing is expected to generate 17.78 times less return on investment than Rigel Pharmaceuticals. But when comparing it to its historical volatility, The Boeing is 4.56 times less risky than Rigel Pharmaceuticals. It trades about 0.1 of its potential returns per unit of risk. Rigel Pharmaceuticals is currently generating about 0.37 of returns per unit of risk over similar time horizon. If you would invest  1,363  in Rigel Pharmaceuticals on September 1, 2024 and sell it today you would earn a total of  1,398  from holding Rigel Pharmaceuticals or generate 102.57% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

The Boeing  vs.  Rigel Pharmaceuticals

 Performance 
       Timeline  
Boeing 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days The Boeing has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Boeing is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Rigel Pharmaceuticals 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Rigel Pharmaceuticals are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating technical and fundamental indicators, Rigel Pharmaceuticals disclosed solid returns over the last few months and may actually be approaching a breakup point.

Boeing and Rigel Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Boeing and Rigel Pharmaceuticals

The main advantage of trading using opposite Boeing and Rigel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Boeing position performs unexpectedly, Rigel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rigel Pharmaceuticals will offset losses from the drop in Rigel Pharmaceuticals' long position.
The idea behind The Boeing and Rigel Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments